ACHV Market Cap History



Below is a table of the ACHV market cap history going back to 5/24/2018:

Date ACHV Market Cap
5/24/201813.41M
8/8/201815.56M
11/7/201815.12M
3/14/201916.47M
5/15/201928.97M
8/8/201914.98M
2/28/20113.86B
11/6/20198.77M
3/13/20209.72M
5/14/202014.63M
7/31/202025.57M
11/12/202032.70M
3/11/202174.41M
5/13/202155.48M
8/12/202171.55M
11/9/202178.65M
3/10/202263.67M
5/12/202261.87M
11/10/202219.91M
3/16/202379.61M
5/9/2023158.94M
8/14/2023112.92M
11/9/202388.68M

Also see: ACHV Shares Outstanding History
and ACHV YTD Return
ACHV Historical Market Cap:
+41.28% CAGR
ACHV Historical Market Cap: +41.28% CAGR

Mouse over chart for data details
5/24/2018 ...11/9/2023
Achieve Life Sciences is a pharmaceutical company engaged in the development and commercialization of cytisinicline for smoking cessation and nicotine addiction. Co.'s product candidate, cytisinicline, is a naturally occurring plant-based alkaloid from the seeds of the Laburnum anagyroides plant. Cytisinicline is structurally similar to nicotine and has a dual-acting mechanism of action that is both agonistic and antagonistic. Cytisinicline interacts with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms through agonistic binding to nicotine receptors and by reducing the reward and satisfaction associated with nicotine through antagonistic properties. We show 23 historical shares outstanding datapoints in our ACHV shares outstanding history coverage, used to compute ACHV market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ACHV market cap history over the course of time is important for investors interested in comparing ACHV's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ACHV versus a peer is one thing; comparing ACHV market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ACHV can fluctuate over the course of history. With this page we aim to empower investors researching ACHV by allowing them to research the ACHV market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ACHV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Achieve Life Science (ACHV) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ACLX Market Cap History
ACON Market Cap History
ACOR Market Cap History
ACRS Market Cap History
ACRV Market Cap History
ACRX Market Cap History
ACST Market Cap History
ACXP Market Cap History
ADGI Market Cap History
ADIL Market Cap History
More Healthcare companies »

 

ACHV Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.